Neuraxis (NASDAQ: NRXS) director now holds 67K shares after stock grant

Rhea-AI Filing Summary

Ferge Kristin A reported acquisition or exercise transactions in this Form 4 filing.

Neuraxis, INC director Kristin A. Ferge received a grant of 31,134 shares of common stock on 2026-08-13 at a reported value of $6.28 per share. The shares were issued as compensation for services as an independent director, bringing her directly held common stock position to 67,072 shares after the award.

Insider Trade Summary

Net Buyer: 31,134 shares

Net Buy 1 txn

Insider Ferge Kristin A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	31,134	$6.28	$196K

Holdings After Transaction: Common Stock — 67,072 shares (Direct)

Footnotes (1)

1. F1. These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.

Key Figures

Shares granted: 31,134 shares Grant valuation price: $6.28 per share Shares owned after grant: 67,072 shares

3 metrics

Shares granted 31,134 shares Common Stock grant to director on 2026-08-13 as compensation

Grant valuation price $6.28 per share Reported value per share for the 31,134-share Common Stock award

Shares owned after grant 67,072 shares Total directly held NRXS Common Stock following the reported transaction

Key Terms

Grant, award, or other acquisition, independent director, direct ownership

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

independent director financial

"compensation for services as independent director of the Issuer"

An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.

direct ownership financial

"ownership_type: direct; ownership_code: D"

FAQ

What did NRXS director Kristin A. Ferge report on this Form 4?

Kristin A. Ferge reported a grant of 31,134 NRXS common shares on 2026-08-13. The award was issued as compensation for her services as an independent director, increasing her directly held stake to 67,072 shares.

How many NRXS shares were granted to Kristin A. Ferge and at what value?

Kristin A. Ferge was granted 31,134 NRXS common shares at a reported value of $6.28 per share. This grant was characterized as compensation for board service rather than an open-market purchase or sale.

What is Kristin A. Ferge’s NRXS ownership after this reported transaction?

Following the reported grant, Kristin A. Ferge directly holds 67,072 NRXS common shares. This total reflects the 31,134-share compensation award added to her prior holdings as disclosed in the Form 4 data.

Was the NRXS Form 4 transaction by Kristin A. Ferge a market buy or a compensation grant?

The Form 4 shows a compensation grant, not a market purchase. Code “A” and a footnote state the 31,134 shares of NRXS common stock were issued as compensation for her independent director services.

Does the NRXS Form 4 indicate any stock sales or derivative exercises by Kristin A. Ferge?

No stock sales or derivative exercises are listed; it reports only a single equity grant of 31,134 NRXS common shares. The filing’s transaction summary shows one acquisition and no sales, gifts, or exercises in this report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 06:29 PM Accepted by SEC EDGAR 08/17/2026 - 06:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ferge Kristin A

(Last) (First) (Middle)

11611 N. MERIDIAN ST,

SUITE 330

(Street)

CARMEL INDIANA 46032

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuraxis, INC [ NRXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2026		A		31,134(1)	A	$6.28(1)	67,072	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.

	/s/ Kristin Ferge	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)